-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, Fqp5wWwKrTV2M1X6XwM9RSBe1QWoSXQvQwoWlcUnEwRHV9tCYpfZ8Cgr1OFhtme/ /oApcucTURmtHGKYubbjpA== 0000899140-04-000241.txt : 20040218 0000899140-04-000241.hdr.sgml : 20040218 20040218171545 ACCESSION NUMBER: 0000899140-04-000241 CONFORMED SUBMISSION TYPE: SC 13D/A PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20040218 GROUP MEMBERS: WARBURG PINCUS & CO. GROUP MEMBERS: WARBURG PINCUS LLC FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: WARBURG PINCUS EQUITY PARTNERS LP CENTRAL INDEX KEY: 0001075598 FILING VALUES: FORM TYPE: SC 13D/A BUSINESS ADDRESS: STREET 1: 466 LEXINGTON AVE. CITY: NEW YORK STATE: NY ZIP: 10017 BUSINESS PHONE: 2128780600 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: INTERMUNE INC CENTRAL INDEX KEY: 0001087432 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 943296648 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13D/A SEC ACT: 1934 Act SEC FILE NUMBER: 005-60673 FILM NUMBER: 04613913 BUSINESS ADDRESS: STREET 1: 3280 BAYSHORE STREET 2: BLVD CITY: BRISBANE STATE: CA ZIP: 94005 BUSINESS PHONE: 415 466 2200 MAIL ADDRESS: STREET 1: 3280 BAYSHORE BLVD CITY: BRISBANE STATE: CA ZIP: 94005 FORMER COMPANY: FORMER CONFORMED NAME: INTERMUNE PHARMACEUTICALS INC DATE OF NAME CHANGE: 20000121 SC 13D/A 1 w1338817.txt AMENDMENT NO. 1 TO SCHEDULE 13D SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D/A Under the Securities Exchange Act of 1934 (Amendment No. 1) InterMune, Inc. - -------------------------------------------------------------------------------- (Name of Issuer) Common Stock, par value $0.001 per share - -------------------------------------------------------------------------------- (Title of Class of Securities) 45885B 10 0 - -------------------------------------------------------------------------------- (CUSIP Number) Scott A. Arenare, Esq. Managing Director and General Counsel Warburg Pincus LLC 466 Lexington Avenue New York, New York 10017 (212) 878-0600 (Name, Address and Telephone Number of Person - -------------------------------------------------------------------------------- Authorized to Receive Notices and Communications) Copies to: Peter H. Jakes, Esq. Willkie Farr & Gallagher LLP 787 Seventh Avenue New York, New York 10019 (212) 728-8000 February 18, 2004 - -------------------------------------------------------------------------------- (Date of Event which Requires Filing of this Statement) If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of ss.ss.240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box: [ ] Page 1 of 10 SCHEDULE 13D/A - --------------------- ------------------ CUSIP No. 45885B 10 Page 2 of 10 Pages - --------------------- ------------------ - ----------- -------------------------------------------------------------------- 1 NAME OF REPORTING PERSON I.R.S. IDENTIFICATION NO. OF ABOVE PERSON Warburg, Pincus Equity Partners, L.P. ID Number 13-3536060 - ----------- -------------------------------------------------------------------- 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) [ ] (b) [X] - ----------- -------------------------------------------------------------------- 3 SEC USE ONLY - ----------- -------------------------------------------------------------------- 4 SOURCE OF FUNDS* WC - ----------- -------------------------------------------------------------------- 5 CHECK IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) or 2(e) [ ] - ----------- -------------------------------------------------------------------- 6 CITIZENSHIP OR PLACE OF ORGANIZATION Delaware - --------------------- --------- ------------------------------------------------ 7 SOLE VOTING POWER 0 --------- ------------------------------------------------ 8 SHARED VOTING POWER NUMBER OF SHARES BENEFICIALLY 4,406,590 (see Item 5(b) of this Schedule 13D) OWNED BY EACH --------- ------------------------------------------------ REPORTING PERSON 9 SOLE DISPOSITIVE POWER WITH WITH 0 --------- ------------------------------------------------ 10 SHARED DISPOSITIVE POWER 4,406,590 (see Item 5(b) of this Schedule 13D) - ----------- -------------------------------------------------------------------- 11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 4,406,590 (see Item 5(b) of this Schedule 13D) - ----------- -------------------------------------------------------------------- 12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS) [ ] - ----------- -------------------------------------------------------------------- 13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11) 13.8% (see Item 5(a) of this Schedule 13D) - ----------- -------------------------------------------------------------------- 14 TYPE OF REPORTING PERSON (SEE INSTRUCTIONS) PN - ----------- -------------------------------------------------------------------- SCHEDULE 13D/A - --------------------- ------------------ CUSIP No. 45885B 10 Page 3 of 10 Pages - --------------------- ------------------ - ----------- -------------------------------------------------------------------- 1 NAME OF REPORTING PERSON I.R.S. IDENTIFICATION NO. OF ABOVE PERSON Warburg Pincus & Co. ID Number 13-6358475 - ----------- -------------------------------------------------------------------- 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) [ ] (b) [X] - ----------- -------------------------------------------------------------------- 3 SEC USE ONLY - ----------- -------------------------------------------------------------------- 4 SOURCE OF FUNDS* WC - ----------- -------------------------------------------------------------------- 5 CHECK IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) or 2(e) [ ] - ----------- -------------------------------------------------------------------- 6 CITIZENSHIP OR PLACE OF ORGANIZATION New York general partnership - --------------------- --------- ------------------------------------------------ 7 SOLE VOTING POWER 0 --------- ------------------------------------------------ 8 SHARED VOTING POWER NUMBER OF SHARES BENEFICIALLY 4,406,590 (see Item 5(b) of this Schedule 13D) OWNED BY EACH --------- ------------------------------------------------ REPORTING PERSON 9 SOLE DISPOSITIVE POWER WITH WITH 0 --------- ------------------------------------------------ 10 SHARED DISPOSITIVE POWER 4,406,590 (see Item 5(b) of this Schedule 13D) - ----------- -------------------------------------------------------------------- 11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 4,406,590 (see Item 5(a) of this Schedule 13D) - ----------- -------------------------------------------------------------------- 12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS) [ ] - ----------- -------------------------------------------------------------------- 13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11) 13.8% (see Item 5(a) of this Schedule 13D) - ----------- -------------------------------------------------------------------- 14 TYPE OF REPORTING PERSON (SEE INSTRUCTIONS) PN - ----------- -------------------------------------------------------------------- SCHEDULE 13D/A - --------------------- ------------------ CUSIP No. 45885B 10 Page 4 of 10 Pages - --------------------- ------------------ - ----------- -------------------------------------------------------------------- 1 NAME OF REPORTING PERSON I.R.S. IDENTIFICATION NO. OF ABOVE PERSON Warburg Pincus LLC (formerly E.M. Warburg Pincus & Co., LLC) ID Number #13-3536050 - ----------- -------------------------------------------------------------------- 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) [ ] (b) [X] - ----------- -------------------------------------------------------------------- 3 SEC USE ONLY - ----------- -------------------------------------------------------------------- 4 SOURCE OF FUNDS* WC - ----------- -------------------------------------------------------------------- 5 CHECK IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) or 2(e) [ ] - ----------- -------------------------------------------------------------------- 6 CITIZENSHIP OR PLACE OF ORGANIZATION New York limited liability company - --------------------- --------- ------------------------------------------------ 7 SOLE VOTING POWER 0 --------- ------------------------------------------------ 8 SHARED VOTING POWER NUMBER OF SHARES BENEFICIALLY 4,406,590 (see Item 5(b) of this Schedule 13D) OWNED BY EACH --------- ------------------------------------------------ REPORTING PERSON 9 SOLE DISPOSITIVE POWER WITH WITH 0 --------- ------------------------------------------------ 10 SHARED DISPOSITIVE POWER 4,406,590 (see Item 5(b) of this Schedule 13D) - ----------- -------------------------------------------------------------------- 11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 4,406,590 (see Item 5(a) of this Schedule 13D) - ----------- -------------------------------------------------------------------- 12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS) [ ] - ----------- -------------------------------------------------------------------- 13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11) 13.8% (see Item 5(a) of this Schedule 13D) - ----------- -------------------------------------------------------------------- 14 TYPE OF REPORTING PERSON (SEE INSTRUCTIONS) OO - ----------- -------------------------------------------------------------------- This Amendment No. 1 amends the Schedule 13D originally filed on December 4, 2003 (the "Original 13D") on behalf of Warburg, Pincus Equity Partners, L.P., a Delaware limited partnership ("WPEP"), Warburg Pincus & Co., a New York general partnership ("WP"), and Warburg Pincus LLC, a New York limited liability company ("WP LLC" and, together with WPEP and WP, the "Reporting Entities"). This Amendment No. 1 to the Original Schedule 13D relates to the common stock, $0.001 per share (the "Common Stock"), of InterMune, Inc., a Delaware corporation (the "Company"). The holdings of Common Stock of WPEP in this Amendment No. 1 to the Original Schedule 13D include certain shares of Common Stock which may be deemed to be beneficially owned by Warburg, Pincus Netherlands Equity Partners I, C.V. ("WPNEP I"), Warburg, Pincus Netherlands Equity Partners II, C.V. ("WPNEP II") and Warburg, Pincus Netherlands Equity Partners III, C.V. ("WPNEP III" and, together with WPNEP I, WPNEP II and WPEP, the "Investors"). WP, WP LLC and the Investors are referred to herein as the "Group Members." Unless otherwise indicated herein, each capitalized term used but not otherwise defined herein shall have the meaning ascribed to such term in the Original Schedule 13D. The Group Members are making this single joint filing because they may be deemed to constitute a "group" within the meaning of the Securities Exchange Act of 1934, as amended. Each Group Member disclaims beneficial ownership of all of the shares of Common Stock, other than those reported herein as being owned by it. Item 3. Source and Amount of Funds or Other Consideration. Item 3 of the Original 13D is hereby amended by adding the following paragraph to the end of the discussion: Page 5 of 10 The total amount of funds used by each Investor to purchase the shares of Common Stock as described herein was furnished from the working capital of such Investor. The total amount of funds used by the Investors to purchase shares of Common Stock pursuant to the open market transactions set forth on Schedule II attached hereto was $9,089,887.20, net of brokerage commissions. Item 5. Interest in Securities of the Issuer. Items 5(a), (b) and (c) of the Original Schedule 13D are hereby amended by adding the following paragraphs at the end of their respective discussion: (a) Due to their respective relationships with the Investors and each other, each of the Reporting Entities may be deemed to beneficially own an aggregate of 4,406,590 shares of Common Stock as of February 18, 2004, by virtue of the Investors' ownership of such shares as of such date. The 4,406,590 shares of Common Stock which the Reporting Entities may be deemed to beneficially own represent approximately 13.8% of the shares of Common Stock (based on the Company's Quarterly Report on Form 10-Q for the quarter ended September 30, 2003 disclosing that 31,818,709 shares of Common Stock were outstanding as of November 4, 2003). (b) Each of the Investors shares the power to vote or to direct the vote and to dispose or direct the disposition of the 4,406,590 shares of common stock it may be deemed to beneficially own as of February 18, 2004. Each of the Reporting Entities shares the power to vote or to direct the vote and to dispose or to direct the disposition of the 4,406,590 shares of Common Stock it may be deemed to beneficially own as of February 18, 2004. Page 6 of 10 (c) The Investors acquired shares of Common Stock in the open market transactions set forth on Schedule II attached hereto. Except as described in Schedule II, no transactions in Common Stock were effected during the last 60 days by the Reporting Entities or any of the persons set forth on Schedule I or in Item 2(d) of the Original 13D. Page 7 of 10 SIGNATURES After reasonable inquiry and to the best of our knowledge and belief, the undersigned certify that the information set forth in this statement is true, complete and correct. Dated: February 18, 2004 WARBURG, PINCUS EQUITY PARTNERS, L.P. By: Warburg Pincus & Co., General Partner By: /s/ Scott Arenare ------------------------------ Name: Scott A. Arenare Title: Partner Dated: February 18, 2004 WARBURG, PINCUS NETHERLANDS EQUITY PARTNERS I, C.V. By: Warburg Pincus & Co., General Partner By: /s/ Scott Arenare ------------------------------ Name: Scott A. Arenare Title: Partner Dated: February 18, 2004 WARBURG, PINCUS NETHERLANDS EQUITY PARTNERS II, C.V. By: Warburg Pincus & Co., General Partner By: /s/ Scott Arenare ------------------------------ Name: Scott A. Arenare Title: Partner Dated: February 18, 2004 WARBURG, PINCUS NETHERLANDS EQUITY PARTNERS III, C.V. By: Warburg Pincus & Co., General Partner By: /s/ Scott Arenare ------------------------------ Name: Scott A. Arenare Title: Partner Page 8 of 10 Dated: February 18, 2004 WARBURG PINCUS & CO. By: /s/ Scott Arenare ------------------------------ Name: Scott A. Arenare Title: Partner Dated: February 18, 2004 WARBURG PINCUS LLC By: /s/ Scott Arenare ------------------------------ Name: Scott A. Arenare Title: Managing Director Page 9 of 10
SCHEDULE II - ------------------- ------------------- ------------------- ------------------------------ Date # of Shares Per Share Price Total Cost (net of brokerage commissions) - ------------------- ------------------- ------------------- ------------------------------ 2/13/04 163,000 $18.3816 $2,996,200.80 - ------------------- ------------------- ------------------- ------------------------------ 2/17/04 108,000 $18.5887 $2,007,579.60 - ------------------- ------------------- ------------------- ------------------------------ 2/18/04 213,000 $19.1836 $4,086,106.80 - ------------------- ------------------- ------------------- ------------------------------ - ------------------- ------------------- ------------------- ------------------------------ Total 484,000 $9,089,887.20 - ------------------- ------------------- ------------------- ------------------------------
Page 10 of 10 -----END PRIVACY-ENHANCED MESSAGE-----